← Leaderboards
Daniel Edward Frigo
Duke University
$4,243,921
Attributed
$5,779,315
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,779,315 · 10
By mechanism
R01$4,391,661 · 3
R03$471,530 · 3
K01$383,196 · 1
R21$372,228 · 1
F32$143,200 · 1
R13$17,500 · 1
Top collaborators
- Ana Aparicio3 shared
- Padmanee Sharma3 shared
- Amado Zurita1 shared
Most similar at Duke University
Same institution · by research overlap
- Anthony R Means$12,026,345
- Charles Nunn$2,635,431
- Jiaoti Huang$7,876,254
- Charles L Nunn$2,234,289
- Sabrina Cote$101,404
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingAndrogensSignal TransductionMalignant Neoplasm Of ProstateMetabolismAndrogen ReceptorSignal PathwayNovel Therapeutic InterventionMalignant NeoplasmsGrowthIn VitroMouse ModelBaseTissuesProstate Cancer CellPre-Clinical ModelCellsPre-ClinicalReceptorBiological MarkersPhosphotransferasesRegulationPublishingTumor
Grant awards (27)
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)$636,578
R01 · FY2025 · CA
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)$604,748
R01 · FY2024 · CA
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)$636,578
R01 · FY2023 · CA
Revisiting Antiangiogenic Therapy to Target Hormone-Sensitive Prostate Cancer Metabolism$566,917
R01 · FY2023 · CA · contact PI
Delineation of the Role of CAMKK2 in Bone-metastatic Prostate Cancer and its Therapeutic Implications$80,265
R03 · FY2023 · CA · contact PI
Delineation of the Role of CAMKK2 in Bone-metastatic Prostate Cancer and its Therapeutic Implications$95,765
R03 · FY2022 · CA · contact PI
FASEB's "The Steroid Hormones and Receptors in Health and Disease Conference - Jointly hosted by FASEB and the International Committee on Rapid Responses to Steroid Hormones (RRSH)"$17,500
R13 · FY2020 · DK · contact PI
Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer$356,152
R01 · FY2019 · CA · contact PI
Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer$382,168
R01 · FY2018 · CA · contact PI
Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer$349,759
R01 · FY2017 · CA · contact PI
Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer$54,358
R01 · FY2017 · CA · contact PI
Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer$349,759
R01 · FY2016 · CA · contact PI
Androgen Receptor- and Myc-Mediated Glutamine Metabolism in Prostate Cancer$169,769
R21 · FY2016 · CA · contact PI
Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer$54,358
R01 · FY2016 · CA · contact PI
Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer$362,041
R01 · FY2015 · CA · contact PI
Androgen Receptor- and Myc-Mediated Glutamine Metabolism in Prostate Cancer$202,459
R21 · FY2015 · CA · contact PI
Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer$38,245
R01 · FY2015 · CA · contact PI
Modulation of Branched-Chain Fatty Acids for the Prevention of Prostate Cancer$70,500
R03 · FY2013 · CA · contact PI
Modulation of Branched-Chain Fatty Acids for the Prevention of Prostate Cancer$75,000
R03 · FY2012 · CA · contact PI
Androgenic Regulation of Autophagy in the Prostate$75,000
R03 · FY2012 · DK · contact PI
Nonclassical signaling of the androgen receptor polyproline domain$138,829
K01 · FY2011 · DK · contact PI
Androgenic Regulation of Autophagy in the Prostate$75,000
R03 · FY2011 · DK · contact PI
Nonclassical signaling of the androgen receptor polyproline domain$138,829
K01 · FY2010 · DK · contact PI
Nonclassical signaling of the androgen receptor polyproline domain$105,538
K01 · FY2009 · DK · contact PI
Estrogen Receptor Beta Pharmacology in the Prostate$50,428
F32 · FY2007 · DK · contact PI
Estrogen Receptor Beta Pharmacology in the Prostate$48,796
F32 · FY2006 · DK · contact PI
Estrogen Receptor Beta Pharmacology in the Prostate$43,976
F32 · FY2005 · DK